Literature DB >> 24552637

Validation of the Persian version of the brief assessment of cognition in schizophrenia in patients with schizophrenia and healthy controls.

Shahrzad Mazhari1, Nooshin Parvaresh, Mahin Eslami Shahrbabaki, Mohammad M Sadeghi, Nouzar Nakhaee, Richard S E Keefe.   

Abstract

AIMS: The Brief Assessment of Cognition in Schizophrenia (BACS) is designed for assessment of cognitive function in patients with schizophrenia. Versions of the BACS in English and other languages have been shown to be as sensitive to cognitive dysfunction as a standard test battery, with the advantage of brief administration and scoring time. The present study aimed to test the concurrent validity of the Persian version of the BACS (Persian-BACS).
METHODS: A group of 50 patients with schizophrenia-spectrum disorders and a group of 50 healthy controls received the Persian-BACS in a first session, and in a second session a standard neurocognitive battery.
RESULTS: Cronbach's alpha for the Persian-BACS was 0.74. All the Persian-BACS subscales were significantly correlated with the corresponding standard neurocognitive subscales and the Pearson correlation of the composite scores from the two instruments was 0.71. Moreover, a one-factor solution was found that accounted for 67.9% of the variance. Finally, the Persian-BACS demonstrated high ability to discriminate patients with schizophrenia from healthy controls.
CONCLUSION: Good psychometric properties of the Persian-BACS suggest that it is a useful tool for assessing cognition in schizophrenic patients with Persian as their primary language.
© 2013 The Authors. Psychiatry and Clinical Neurosciences © 2013 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  Brief Assessment of Cognition in Schizophrenia; Persian; cognition; schizophrenia

Mesh:

Year:  2013        PMID: 24552637     DOI: 10.1111/pcn.12107

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  8 in total

1.  European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Andreas Erfurth; Stefano Barlati; Federico Zanca; Giulia Maria Giordano; Louise Birkedal Glenthøj; Merete Nordentoft; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

Review 2.  A systematic review of research on neuropsychological measures in psychotic disorders from low and middle-income countries: The question of clinical utility.

Authors:  Emmanuel K Mwesiga; Dickens Akena; Nastassja Koen; Richard Senono; Ekwaro A Obuku; Joy Louise Gumikiriza; Reuben N Robbins; Noeline Nakasujja; Dan J Stein
Journal:  Schizophr Res Cogn       Date:  2020-08-24

3.  Investigating Cognitive Functions in Methadone Users in Comparison with Methadone and Methamphetamine Users and Control Group.

Authors:  Mahin Eslami-Shahrbabaki; Delaram Barfehee; Nooshin Parvaresh; Elham Zamani; Ali Soltaninejad; Atefeh Ahmadi
Journal:  Addict Health       Date:  2022-01

4.  Validity and reliability of the Brazilian Portuguese version of the BACS (Brief Assessment of Cognition in Schizophrenia).

Authors:  Geovany Eliberto Araújo; Camilo Brandão de Resende; Ana Cecília Alves Cardoso; Antonio Lúcio Teixeira; Richard S E Keefe; João Vinícius Salgado
Journal:  Clinics (Sao Paulo)       Date:  2015-04       Impact factor: 2.365

5.  Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls.

Authors:  Shahrzad Mazhari; Shokouh Arjmand; Mahin Eslami Shahrbabaki; Elham Karimi Ghoughari
Journal:  Basic Clin Neurosci       Date:  2020-09-01

6.  Cross-cultural adaptation and validation of the Arabic version of the BACS scale (the brief assessment of cognition in schizophrenia) among chronic schizophrenic inpatients.

Authors:  Jean-Pierre Clément; Benjamin Calvet; Chadia Haddad; Pascale Salameh; Souheil Hallit; Sahar Obeid; Georges Haddad
Journal:  BMC Psychiatry       Date:  2021-05-01       Impact factor: 4.144

7.  Validation of the Chinese version of Brief Assessment of Cognition in Schizophrenia.

Authors:  Liang-Jen Wang; Pao-Yen Lin; Yu Lee; Yu-Chi Huang; Su-Ting Hsu; Chi-Fa Hung; Chih-Ken Chen; Yi-Chih Chen; Ya-Ling Wang; Ming-Che Tsai
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-31       Impact factor: 2.570

Review 8.  Assessing cognition in people with severe mental disorders in low- and middle-income countries: a systematic review of assessment measures.

Authors:  Yohannes Gebreegziabhere Haile; Kassahun Habatmu; Andualem Derese; Hetta Gouse; Stephen M Lawrie; Matteo Cella; Atalay Alem
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-06-18       Impact factor: 4.328

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.